At Ars Live, bioengineering professor Aaron Streets explains new cellular science.
NYS Entity Status
NYS Filing Date
JANUARY 17, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - ATLAS TOOLS, LLC
Around the Web
- To better grok how all 37 trillion human cells work, we need new tools
By Cyrus Farivar - Saturday Sep 30, 2017
- Woman Who Sabotaged Fiancé’s Kayak Is Sentenced to Up to 4 Years
By SARAH MASLIN NIR - Wednesday Nov 8, 2017
Angelika Graswald, who prosecutors said had watched her fiancé drown and even moved a paddle out of his reach, was expected to be freed by year’s end.
- NASA launches last of its longtime tracking satellites
By MARCIA DUNN, AP Aerospace Writer - Friday Aug 18, 2017
CAPE CANAVERAL, Fla. (AP) — NASA launched the last of its longtime tracking and communication satellites on Friday, a vital link to astronauts in orbit as well as the Hubble Space Telescope.The end of the era came with a morning liftoff of TDRS-M, the 13th satellite in the Tracking and Data Relay Satellite network . It rode to orbit aboard an unmanned Atlas V rocket."It's like our baby," said NASA's Badri Younes, deputy associate administrator for space communications and navigation."People have invested their soul and their sweat into making it happen" over the decades, Younes said on the eve of launch. "This spacecraft has served us so well."NASA has been launching TDRS satellites since 1983.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]